Mark A. Fishel

3.9k total citations · 3 hit papers
16 papers, 3.1k citations indexed

About

Mark A. Fishel is a scholar working on Physiology, Clinical Biochemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Mark A. Fishel has authored 16 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 4 papers in Clinical Biochemistry and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mark A. Fishel's work include Alzheimer's disease research and treatments (5 papers), Advanced Glycation End Products research (4 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Mark A. Fishel is often cited by papers focused on Alzheimer's disease research and treatments (5 papers), Advanced Glycation End Products research (4 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Mark A. Fishel collaborates with scholars based in United States and Italy. Mark A. Fishel's co-authors include G. Stennis Watson, Suzanne Craft, Stephen R. Plymate, Laura D. Baker, Brenna Cholerton, Mark A. Reger, Pattie S. Green, Charles W. Wilkinson, Pankaj Mehta and Monique M. Cherrier and has published in prestigious journals such as Neurology, Journal of the American Geriatrics Society and Neurobiology of Aging.

In The Last Decade

Mark A. Fishel

16 papers receiving 3.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of Aerobic Exercise on Mild Cognitive Impairment

2010 899 citations Laura D. Baker, Laura L. Frank et al. Archives of Neurology profile →
Intranasal insulin improves cognition and modulates β-amyloid in early AD

2007 660 citations Mark A. Reger, G. Stennis Watson et al. Neurology profile →
Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype

2005 541 citations Mark A. Reger, G. Stennis Watson et al. Neurobiology of Aging profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark A. Fishel United States	10	1.5k	688	570	559	481	16	3.1k
Carol E. Greenwood Canada	37	1.9k 1.3×	536 0.8×	381 0.7×	608 1.1×	347 0.7×	94	4.6k
Julius Popp Switzerland	36	1.5k 1.0×	1.0k 1.5×	513 0.9×	946 1.7×	288 0.6×	112	4.2k
Katsuya Urakami Japan	30	1.4k 0.9×	1.1k 1.6×	404 0.7×	702 1.3×	153 0.3×	116	3.0k
Emily R. Rosario United States	27	1.3k 0.8×	324 0.5×	377 0.7×	562 1.0×	829 1.7×	78	3.3k
Keijo Koivisto Finland	30	1.2k 0.8×	1.4k 2.0×	501 0.9×	410 0.7×	323 0.7×	63	3.4k
Claude Messier Canada	39	1.3k 0.9×	503 0.7×	633 1.1×	1.0k 1.9×	446 0.9×	95	4.4k
Hongxin Dong United States	35	1.5k 1.0×	400 0.6×	535 0.9×	956 1.7×	187 0.4×	91	4.0k
Eeva‐Liisa Helkala Finland	27	2.3k 1.5×	2.4k 3.4×	737 1.3×	410 0.7×	367 0.8×	43	5.4k
Peter Schönknecht Germany	36	1.5k 1.0×	1.5k 2.2×	494 0.9×	583 1.0×	146 0.3×	104	4.1k
Chaim Tarshish United States	19	1.9k 1.3×	1.9k 2.8×	749 1.3×	417 0.7×	458 1.0×	26	4.6k

Countries citing papers authored by Mark A. Fishel

Since Specialization

Citations

This map shows the geographic impact of Mark A. Fishel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Fishel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Fishel more than expected).

Fields of papers citing papers by Mark A. Fishel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Fishel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Fishel. The network helps show where Mark A. Fishel may publish in the future.

Co-authorship network of co-authors of Mark A. Fishel

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Fishel. A scholar is included among the top collaborators of Mark A. Fishel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Fishel. Mark A. Fishel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Baker, Laura D., Sanjay Asthana, Brenna Cholerton, et al.. (2011). Cognitive response to estradiol in postmenopausal women is modified by high cortisol. Neurobiology of Aging. 33(4). 829.e9–829.e20. 20 indexed citations

Baker, Laura D., Laura L. Frank, Karen E. Foster‐Schubert, et al.. (2010). Aerobic Exercise Improves Cognition for Older Adults with Glucose Intolerance, A Risk Factor for Alzheimer's Disease. Journal of Alzheimer s Disease. 22(2). 569–579. 208 indexed citations

Baker, Laura D., Laura L. Frank, Karen E. Foster‐Schubert, et al.. (2010). Effects of Aerobic Exercise on Mild Cognitive Impairment. Archives of Neurology. 67(1). 71–9. 899 indexed citations breakdown →

Reger, Mark A., G. Stennis Watson, Pattie S. Green, et al.. (2008). Intranasal Insulin Administration Dose-Dependently Modulates Verbal Memory and Plasma Amyloid-β in Memory-Impaired Older Adults. Journal of Alzheimer s Disease. 13(3). 323–331. 441 indexed citations

Reger, Mark A., G. Stennis Watson, Charles W. Wilkinson, et al.. (2007). Intranasal insulin improves cognition and modulates β-amyloid in early AD. Neurology. 70(6). 440–448. 660 indexed citations breakdown →

Leverenz, James B., Mark A. Fishel, Elaine R. Peskind, et al.. (2006). Lewy Body Pathology in Familial Alzheimer Disease. Archives of Neurology. 63(3). 370–370. 100 indexed citations

Craft, Suzanne, Mark A. Reger, Laura D. Baker, et al.. (2006). O3–05–05: Therapeutic effects of daily intranasal insulin administration in early Alzheimer's disease. Alzheimer s & Dementia. 2(3S_Part_3). 2 indexed citations

Fishel, Mark A., G. Stennis Watson, Thomas J. Montine, et al.. (2005). Hyperinsulinemia Provokes Synchronous Increases in Central Inflammation and β-Amyloid in Normal Adults. Archives of Neurology. 62(10). 1539–44. 179 indexed citations

Bowen, James D., Richard Kamin, James B. Leverenz, et al.. (2005). Interrater Reliability and Accuracy in Identifying Ischemic Strokes Using Computed Tomography Scans in People with Dementia. Journal of the American Geriatrics Society. 53(10). 1743–1747. 5 indexed citations

10.

Reger, Mark A., G. Stennis Watson, William H. Frey, et al.. (2005). Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype. Neurobiology of Aging. 27(3). 451–458. 541 indexed citations breakdown →

11.

Watson, G. Stennis, Brenna Cholerton, Mark A. Reger, et al.. (2005). Preserved Cognition in Patients With Early Alzheimer Disease and Amnestic Mild Cognitive Impairment During Treatment With Rosiglitazone. American Journal of Geriatric Psychiatry. 13(11). 950–958. 66 indexed citations

12.

Fishel, Mark A.. (2005). Hyperinsulinemia Provokes Synchronous Increases in Central Inflammation and -Amyloid in Normal Adults. Archives of Neurology. 62(10). 1539–1544. 4 indexed citations

13.

Green, Pattie S., David G. Cook, G. Stennis Watson, et al.. (2004). P3-012 Effects of rosiglitazone treatment on serum amyloid-beta 1–40 and 1–42 in patients with early Alzheimer's disease. Neurobiology of Aging. 25. S354–S355. 7 indexed citations

14.

Watson, G. Stennis, Mark A. Reger, Brenna Cholerton, et al.. (2004). O4-05-05 Rosiglitazone preserves cognitive functions in patients with early Alzheimer's disease. Neurobiology of Aging. 25. S83–S83. 4 indexed citations

15.

Fishel, Mark A., Debby W. Tsuang, Murray A. Raskind, et al.. (2000). Lewy body pathology in familial (presenilin-2) Alzheimer's disease. Neurobiology of Aging. 21. 66–66. 1 indexed citations

16.

Costa‐Mallen, Paola, Harvey Checkoway, Mark A. Fishel, et al.. (2000). The Eco RV genetic polymorphism of human monoamine oxidase type A is not associated with Parkinson's disease and does not modify the effect of smoking on Parkinson's disease. Neuroscience Letters. 278(1-2). 33–36. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact